Sector ratings Kymera Therapeutics, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 21:00:00 09/06/2026 BST			5-day change	1st Jan Change
76.91 ^USD	+4.00%		+7.88%	-1.16%

06-09	Kymera Therapeutics Unlocks $20 Million Milestone After Dosing First Participant in KT-485 Phase 1 Trial	MT
06-08	Kymera Therapeutics, Inc. Announces Executive Changes	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
KYMERA THERAPEUTICS, INC.	6.33B	-	BBB	-		-
LONZA GROUP AG	43.4B		AAA
REVOLUTION MEDICINES, INC.	31.79B	-	B	-		-
IQVIA HOLDINGS INC.	31.09B		AAA
BEONE MEDICINES AG	29.81B		-
CELLTRION, INC.	24.46B		A
EUROFINS SCIENTIFIC SE	13.19B		AA
MEDPACE HOLDINGS, INC.	13.33B		BBB
ASCENDIS PHARMA A/S	13.24B	-	-	-		-		-
IONIS PHARMACEUTICALS, INC.	12.33B	-	A	-		-
ICON PUBLIC LIMITED COMPANY	11.62B		AAA
REGENCELL BIOSCIENCE HOLDINGS LIMITED	10.06B	-	-	-	-	-	-	-
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	9.14B		AA
TEMPUS AI, INC.	8.77B		A			-
BLUEPRINT MEDICINES CORPORATION	8.38B	-	BB	-		-	-	-
BIO-TECHNE CORPORATION	8.52B		AA
ABIVAX	7.9B	-	BBB	-		-
QIAGEN N.V.	7.81B		AAA
ALKERMES PLC	7.38B		A
PRAXIS PRECISION MEDICINES, INC.	6.98B	-	B	-		-
Average	15.28B		A
Weighted average by Cap.			A

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!